| 持有 双鹭药业(002038)的基金 |
| 报告期：2024-06-30 |
| 序号 |
基金代码 |
基金简称 |
持仓市值(元) |
持仓数量(股) |
占基金净值比例(%) |
| 1 | 159992 | 银华中证创新药产业ETF | 43,601,399.05 | 5,916,065.00 | 0.69 |
| 2 | 512100 | 南方中证1000ETF | 24,513,357.00 | 3,326,100.00 | 0.10 |
| 3 | 515120 | 广发中证创新药产业ETF | 18,905,524.00 | 2,565,200.00 | 0.69 |
| 4 | 161039 | 富国中证1000指数增强(LOF) | 5,013,074.00 | 680,200.00 | 0.21 |
| 5 | 161122 | 易方达生物科技指数分级 | 4,889,272.74 | 663,402.00 | 0.73 |
| 6 | 501010 | 汇添富中证生物科技指数(LOF)C | 2,953,896.00 | 400,800.00 | 0.13 |
| 7 | 501009 | 汇添富中证生物科技指数(LOF)A | 2,953,896.00 | 400,800.00 | 0.13 |
| 8 | 006166 | 建信中证1000指数增强C | 2,791,019.00 | 378,700.00 | 0.21 |
| 9 | 006165 | 建信中证1000指数增强A | 2,791,019.00 | 378,700.00 | 0.21 |
| 10 | 004410 | 招商央视财经50指数C | 1,158,468.19 | 157,187.00 | 0.18 |
| 11 | 217027 | 招商央视财经50指数A | 1,158,468.19 | 157,187.00 | 0.18 |
| 12 | 003865 | 创金合信量化多因子股票C | 886,611.00 | 120,300.00 | 0.30 |
| 13 | 002210 | 创金合信量化多因子股票A | 886,611.00 | 120,300.00 | 0.30 |
| 14 | 165312 | 建信央视财经50指数分级 | 601,738.39 | 81,647.00 | 0.18 |
| 15 | 159965 | 中融央视财经50ETF | 144,820.50 | 19,650.00 | 0.19 |
| 16 | 007795 | 申万菱信中证500指数增强C | 80,333.00 | 10,900.00 | 0.02 |
| 17 | 002510 | 申万菱信中证500指数增强A | 80,333.00 | 10,900.00 | 0.02 |
| 18 | 159918 | 嘉实中创400ETF | 79,596.00 | 10,800.00 | 0.16 |
| 19 | 162413 | 华宝中证1000指数分级 | 34,639.00 | 4,700.00 | 0.10 |
| 20 | 001073 | 华泰柏瑞量化绝对收益混合 | 4,422.00 | 600.00 | 0.01 |
| 21 | 005727 | 嘉实中创400ETF联接C | 1,474.00 | 200.00 | 0.00 |
| 22 | 070030 | 嘉实中创400ETF联接A | 1,474.00 | 200.00 | 0.00 |
